Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.

Biotechnology

Health Care

Gibson Oncology

Gibson Oncology's headquarters in Miami Beach, FL, United States

Randall B Riggs

Elizabeth L Rogers

Mark S Cushman

Mark C Rogers

Michael Zinner

Fred Mermelstein

Mark D. Baganz

Desmond A. Brown

Danzhou Yang

Graeme F. Woodworth

Pooran Chand

The Scientific Advisory Team at Gibson Oncology provides expert guidance and strategic insights for the development and progression of the Indenoisoquinolines. They evaluate clinical trial data, advise on research methodologies, and ensure that the investigational treatments align with the latest scientific advancements and regulatory standards.

Scientific Advisory Team

The Leadership Team at Gibson Oncology spearheads the company's strategic direction, oversees clinical development, and ensures operational excellence in advancing Phase II trials of Indenoisoquinolines. Comprising the company's founders and key executives, this team drives efforts to deliver innovative, patient-friendly cancer treatments.

Leadership Team

Gibson Oncology

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Gibson Oncology

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Related companies